Paget disease (breast)
Citation, DOI, disclosures and article data
At the time the article was created Jeffrey Kao had no recorded disclosures.View Jeffrey Kao's current disclosures
Paget disease of the breast, which is also known as Paget disease of the nipple, has traditionally been described as a form of breast malignancy characterized by infiltration of the nipple epidermis by malignant cells. Although most cases have underlying focus or foci of in situ or invasive carcinomas, some cases of Paget disease are confined to the skin of the nipple-areola without underlying neoplastic foci.
The condition can represent 1-5% of breast malignancies. The average age at diagnosis is around the 6th decade (53-59 years).
Eczematous appearing changes of the nipple include reddening, scaling, hyperkeratosis, and crusting of the nipple surface.
Mammary Paget disease can be classified into four clinical stages:
- stage 0: lesion is confined to the epidermis, without underlying ductal carcinoma in situ (DCIS) of the breast
- stage 1: associated with DCIS just beneath the nipple
- stage 2: associated with extensive DCIS
- stage 3: associated with invasive ductal carcinoma
In most cases of Paget of the breast, there are malignant ductal cells that extend to the nipple surface through the terminal lactiferous ducts.
Malignant epithelial (Paget) cells infiltrate and proliferate in the epidermis, causing an eczema-like rash of the nipple and the areolar skin. There are several histologic variants of Paget disease including:
- adenocarcinoma-like cell type
- spindle cell type
- anaplastic cell type
- acantholytic cell type
- pigmented cell type
Mammary Paget disease can be undetectable on mammography in ~50% of cases 2. Features that may be evident on mammography include skin thickening, nipple retraction, subareolar or more diffuse malignant microcalcifications, and discrete subareolar mass(es).
MR imaging may play an important role in the selection of patients with Paget disease for breast-conserving therapy if there is no clinical or mammographic evidence of breast carcinoma. Abnormal nipple enhancement and linear clumped enhancement indicative of DCIS in association with Paget disease.
Treatment and prognosis
Traditionally, treatment has been a mastectomy with nodal dissection. However, with MRI, breast-conserving therapy is more frequently being used.
History and etymology
Paget disease of the breast is named after Sir James Paget (1814-1899), the British surgeon and pathologist, who first described it in 1874 6.
- 1. Conant EF, Brennecke CM. Breast imaging, case review. Mosby Inc. (2006) ISBN:0323017460. Read it at Google Books - Find it at Amazon
- 2. Burke ET, Braeuning MP, Mclelland R et-al. Paget disease of the breast: a pictorial essay. Radiographics. 18 (6): 1459-64. Radiographics (abstract) - Pubmed citation
- 3. Da costa D, Taddese A, Cure ML et-al. Common and unusual diseases of the nipple-areolar complex. Radiographics. 2007;27 Suppl 1 : S65-77. doi:10.1148/rg.27si075512 - Pubmed citation
- 4. Echevarria JJ, Lopez-ruiz JA, Martin D et-al. Usefulness of MRI in detecting occult breast cancer associated with Paget's disease of the nipple-areolar complex. Br J Radiol. 2004;77 (924): 1036-9. doi:10.1259/bjr/94607773 - Pubmed citation
- 5. Paredes ES. Atlas of mammography. Lippincott Williams & Wilkins. (2007) ISBN:0781764335. Read it at Google Books - Find it at Amazon
- 6. Ellis H. Sir James Paget: Paget's disease of the nipple, Paget's disease of bone. (2013) Journal of perioperative practice. 23 (4): 91-2. doi:10.1177/175045891302300406 - Pubmed
- 7. Lim HS, Jeong SJ, Lee JS, Park MH, Kim JW, Shin SS, Park JG, Kang HK. Paget disease of the breast: mammographic, US, and MR imaging findings with pathologic correlation. (2011) Radiographics : a review publication of the Radiological Society of North America, Inc. 31 (7): 1973-87. doi:10.1148/rg.317115070 - Pubmed